Concepedia

Jose Lobo

JL

8

Publications

2.4K

Citations

8

H-Index

2005

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Pfizer (United States)

Immunovaccine (Canada)

Harvard University

Pediatrics and Genetics

Jose Lobo is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, signal transduction, and molecular imaging.

Top concepts

Publications per year

2005–2020

8

Publications

8

BRAF mutation predicts sensitivity to MEK inhibition

David B. Solit, Levi A. Garraway, Christine A. Pratilas et al. · Nature · 2005 · 1.3K citations · Full text

, , +6

The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells

Qing‐Bai She, David B. Solit, Qing Ye et al. · Cancer Cell · 2005 · 417 citations

, , +11

RETRACTED: Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling

Qing‐Bai She, Sarat Chandarlapaty, Qing Ye et al. · PLoS ONE · 2008 · 315 citations · Full text

Pulsatile Administration of the Epidermal Growth Factor Receptor Inhibitor Gefitinib Is Significantly More Effective than Continuous Dosing for Sensitizing Tumors to Paclitaxel

David B. Solit, Yuhong She, Jose Lobo et al. · Clinical Cancer Research · 2005 · 134 citations · Full text

3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition

David B. Solit, Elmer Santos, Christine A. Pratilas et al. · Cancer Research · 2007 · 64 citations · Full text

Rows per page

1–5 of 8